Tuesday, July 5, 2022
No Result
View All Result
Medical Finance
  • Home
  • News
  • Interviews
  • Mediknowledge
  • Insights From Industry
  • Thought Leaders
  • Coronavirus
  • Whitepapers
  • Home
  • News
  • Interviews
  • Mediknowledge
  • Insights From Industry
  • Thought Leaders
  • Coronavirus
  • Whitepapers
No Result
View All Result
Medical Finance
No Result
View All Result
Home News

AI-driven solution predicts RNA and DNA binding sites to accelerate rational drug discovery

by Medical Finance
in News
AI-driven solution predicts RNA and DNA binding sites to accelerate rational drug discovery
9
SHARES
99
VIEWS
Share on FacebookShare on Twitter

The iMolecule group from Skoltech has developed an artificial intelligence-driven solution that uses data on the structure of RNA or DNA molecules to identify sites on them where interaction with potential drug candidates can occur. Knowledge of these binding sites allows pharmaceutical companies to discover new medications -; including antiviral agents -; in a much more focused and efficient manner. The new solution is also more accurate than prior approaches, because it accounts for how the shape assumed by a nucleic acid molecule affects which binding sites are exposed. The study came out in Nucleic Acid Research: Genomics and Bioinformatics.

For a long time, pharmacologists have seen RNA as merely a mediator between DNA -; that is, our genome -; and the functional proteins it encodes, so most drugs target proteins. However, while about 85% of the genome is transcribed into RNAs, only a small fraction of those actually encode proteins. The remaining, noncoding RNAs serve to activate or inactivate certain genes or fulfill other roles by folding into different shapes, called conformations. Since the noncoding functions can take on a pathological dimension, too, RNA and possibly DNA sequences are increasingly recognized as potential drug targets.

Nucleic acids -; DNA and RNA -; can participate in signaling, for example, and we could target that or any other process they are involved in. This could be a promising strategy for undruggable protein targets, for example, disordered proteins or proteins that lack convenient binding sites. And then there’s also pathogenic RNA foreign to the body, for example in viruses, such as SARS-CoV-2 or HIV.”


Petr Popov, principal investigator of the study, Skoltech Assistant Professor

To unlock the potential of all those tentative drug targets, pharmacologists require tools for screening large libraries of chemical compounds to see which of them interact with nucleic acids and what the precise binding spots are.

“We created this new solution by adapting our prior work with proteins,” Popov explained. “Nucleic acid three-dimensional structures are encoded as high-dimensional tensors. Once this is done, a computer vision algorithm ‘looks’ at the tensors and highlights the areas in the structure that it thinks could serve as binding sites. After the conformation and the binding site have been detected, a more focused drug discovery campaign can be initiated. So our work is a small step toward rational drug discovery in contrast to the blind screening, which becomes less reliable with growing chemical libraries.”

There’s an added twist that has to do with the shape of RNA and DNA molecules. They are literally prone to twist and tangle up into distinct shapes. These so-called conformation changes alter the properties of the molecules, including what binding sites are exposed. The conventional approaches only consider the nucleic acid sequences but are blind to conformation and therefore necessarily inaccurate.

“Most earlier methods only worked with RNA, and specifically, with a single chain. Ours works with DNA and with two or more chains. We can even see additional sites that arise when multiple molecules become entangled,” Igor Kozlovskii, a Skoltech PhD student and the first author of the paper, said.

“A great example of what makes working with methods that ignore conformation problematic is the dominant type of HIV,” he went on. “It has an RNA region targeted by many agents. But even though the nucleic acid sequence is the same, when that molecule changes conformation, this is known to have an effect on which agents work or don’t. Our neural network predictions actually reproduce this effect, which means they are reliable.”

The new solution has an unexpected application that involves using the method “in reverse.” Instead of recognizing binding sites on a potential target, the algorithm could zoom in on a troublesome agent -; a small molecule such as a hormone -; that is causing a disorder, and distract it.

“So we want to bind those small molecules with something. To do it, we need to reverse-engineer a short nucleic acid fragment, called aptamer, that would serve as a decoy for the hormone or other molecule of interest. Naturally, an aptamer must contain a binding site, and our solution can be applied to design aptamers with improved binding properties,” Popov explained.

Source:

Skolkovo Institute of Science and Technology (Skoltech)

Total
0
Shares
Share 0
Tweet 0
Pin it 0
Share 0
Medical Finance

Medical Finance

Related Posts

Study identifies cellular receptors for alphaviruses shared across mosquitoes, humans, and animals

Saliva tests detect SARS-CoV-2 virus more quickly than nasal swabs

by Medical Finance
July 5, 2022
0

Genetic testing of saliva samples identifies the SARS-CoV-2 virus more quickly than testing of nasal swabs. The research is published...

Study: Antimicrobial Resistance (AMR) In COVID-19 Patients: A Systematic Review and Meta-Analysis (November 2019-June 2021). Image Credit: Kateryna Kon / Shutterstock.com

Antimicrobial resistance in COVID-19

by Medical Finance
July 5, 2022
0

The coronavirus disease 2019 (COVID-19) pandemic is caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). As of March...

Researchers explore novel strategy to improve the reprogramming efficiency of human fibroblasts

Optical coherence tomography reveals the beating and development of human heart organoids

by Medical Finance
July 5, 2022
0

Researchers have been using organoids -; 3D organ-like, tightly-packed cell cultures -; as models to study organ development, disease and...

Researchers create a DNA-based fluorescent nanoantenna to monitor the motions of proteins

Using genomics to restore degraded ecosystems

by Medical Finance
July 5, 2022
0

The monumental global task to restore degraded ecosystems will need to include sophisticated technologies such as environmental DNA monitoring to...

First patient-derived stem cell model developed for studying oculocutaneous albinism

Pressure drives sudden burst of rapid and coordinated cellular motion in 3D tumor model

by Medical Finance
July 5, 2022
0

Biological processes such as wound healing and cancer cell invasion rely on the collective and coordinated motion of living cells....

Study reveals a direct correlation between fat browning and consumption of flavan 3-ols

Scientists discover mechanism that enables Listeria-infected cells to escape immune responses

by Medical Finance
July 5, 2022
0

Some "hypervirulent" strains of Listeria monocytogenes have a greater capacity to infect the central nervous system. Scientists from the Institut...

Next Post
Study: Comparison of Moderna Versus Pfizer-Biontech COVID-19 Vaccine Outcomes: A Target Trial Emulation Study In the U.S. Veterans Affairs Healthcare System. Image Credit: BaLL LunLa/Shutterstock

Comparing the Moderna and Pfizer-Biontech vaccines against SARS-CoV-2 infection

Uno single tube reader

High resolution single tube reader

0 0 votes
Article Rating
Subscribe
Login
Notify of
guest
guest
0 Comments
Inline Feedbacks
View all comments

Support

  • Contact
  • Disclaimer
  • Home
  • Privacy Policy
  • Terms And Conditions

Categories

  • Coronavirus
  • Insights From Industry
  • Interviews
  • Mediknowledge
  • News
  • Thought Leaders
  • Whitepapers

More News

  • Study: Effect of Vaccination on Household Transmission of SARS-CoV-2 Delta VOC. Image Credit: TY Lim / Shutterstock.com
    Danish household study shows COVID vaccinates reduce susceptibility and transmissibility
  • Study: Pre-exposure prophylaxis with Evusheld™ elicits limited neutralizing activity against the omicron variant in kidney transplant patients. Image Credit: PHOTOCREO Michal Bednarek/Shutterstock
    Evusheld™ found to poorly neutralize Omicron in kidney transplant patients
  • Home
  • Privacy Policy
  • Contact
  • Disclaimer
  • Terms And Conditions

© 2022 Medical Finance - Latest Financial and Business News

No Result
View All Result
  • Interviews
  • Mediknowledge
  • News
  • Insights From Industry
  • Coronavirus
  • Thought Leaders
  • Whitepapers
wpDiscuz
0
0
Would love your thoughts, please comment.x
()
x
| Reply